首页> 美国卫生研究院文献>Pharmaceutics >Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability Molar Ratio Preparation Methods Physical Stability In Vitro and In Vivo Performance and New Formulation Strategies
【2h】

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability Molar Ratio Preparation Methods Physical Stability In Vitro and In Vivo Performance and New Formulation Strategies

机译:数量的共 - 无定形药物制剂:共同无定形药物制剂的最新进展重点是共同可成形性摩尔比制备方法体外稳定性体外和体内性能以及新的配方策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Co-amorphous drug delivery systems (CAMS) are characterized by the combination of two or more (initially crystalline) low molecular weight components that form a homogeneous single-phase amorphous system. Over the past decades, CAMS have been widely investigated as a promising approach to address the challenge of low water solubility of many active pharmaceutical ingredients. Most of the studies on CAMS were performed on a case-by-case basis, and only a few systematic studies are available. A quantitative analysis of the literature on CAMS under certain aspects highlights not only which aspects have been of great interest, but also which future developments are necessary to expand this research field. This review provides a comprehensive updated overview on the current published work on CAMS using a quantitative approach, focusing on three critical quality attributes of CAMS, i.e., co-formability, physical stability, and dissolution performance. Specifically, co-formability, molar ratio of drug and co-former, preparation methods, physical stability, and in vitro and in vivo performance were covered. For each aspect, a quantitative assessment on the current status was performed, allowing both recent advances and remaining research gaps to be identified. Furthermore, novel research aspects such as the design of ternary CAMS are discussed.
机译:共聚药物输送系统(凸轮)的特征在于形成均匀单相无定形系统的两个或更多个(最初结晶)低分子量组分的组合。在过去的几十年中,凸轮被广泛调查为解决许多活性药物成分的低水溶性挑战的有希望的方法。大部分关于凸轮的研究都在逐个案例的基础上进行,并且只有少数系统研究。在某些方面,在某些方面对凸轮上的文献的定量分析突出显示,这不仅有哪些方面具有很大的兴趣,而且还有哪些未来的发展是扩大这一研究领域的必要条件。本综述提供了使用定量方法的当前发布的凸轮上发布工作的全面更新概述,专注于凸轮的三个关键质量属性,即共同可加工性,物理稳定性和溶出性能。具体而言,覆盖了共同可成形性,药物和共同,制备方法,物理稳定性和体外和体内性能的摩尔比。对于每个方面,对当前状态进行定量评估,允许识别最近的进步和剩余的研究空间。此外,讨论了新的研究方面,例如三元凸轮的设计。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号